154 related articles for article (PubMed ID: 1522928)
1. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of antiviral combination therapy in chronic hepatitis B.
De Man RA; Schalm SW; Heijtink RA; Berk L; Den Ouden J; ten Kate FJ; Chamuleau RA; Reesink HW
Am J Med; 1988 Aug; 85(2A):150-4. PubMed ID: 3044080
[TBL] [Abstract][Full Text] [Related]
4. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B with a combination of acyclovir and human lymphoblastoid interferon.
Schalm SW
Chemioterapia; 1988 Dec; 7 Suppl 3():26-9. PubMed ID: 3248317
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
8. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea.
Song BC; Suh DJ; Lee HC; Chung YH; Lee YS
Hepatology; 2000 Oct; 32(4 Pt 1):803-6. PubMed ID: 11003626
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV
Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882
[TBL] [Abstract][Full Text] [Related]
14. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
Bozkaya H; Ayola B; Lok AS
Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
[TBL] [Abstract][Full Text] [Related]
15. Multicenter retrospective study of response to interferon in chronic hepatitis B.
Martín-Vivaldi R; Nogueras F; Vignote ML; Salmerón J; Aguilar J; Romero M; Andrade R; De la Mata M; Moreno JM; Pérez J; García G; López de Hierro M; Gómez F; Palacios A; Otero S; Suárez E; Poyatos A; Quintero D
Rev Esp Enferm Dig; 2000 Sep; 92(9):561-72. PubMed ID: 11138238
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.
Capalbo M; Palmisano L; Bonino F; Pellas C; Maset J
Ital J Gastroenterol; 1994 Jun; 26(5):238-41. PubMed ID: 7919465
[TBL] [Abstract][Full Text] [Related]
19. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.
Guillevin L; Lhote F; Leon A; Fauvelle F; Vivitski L; Trepo C
J Rheumatol; 1993 Feb; 20(2):289-98. PubMed ID: 8097249
[TBL] [Abstract][Full Text] [Related]
20. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
